HomepageMedicinePharma Pulse 3/15/24:Pharma Dealt Loss Over Discount Program, Adopting New Manufacturing Technologies & more Medicine Pharma Pulse 3/15/24:Pharma Dealt Loss Over Discount Program, Adopting New Manufacturing Technologies & more admin Posted on March 17, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostReal estate sector may touch $1.3tn by 2034: CREDAI Report Next PostPhoebe Philo Finally Talks About Her Return to Fashion You Might Also Like Medicine Degron Therapeutics, Takeda Ink Exclusive License and Collaboration Agreement to Develop Molecule Degraders Targeting Multiple Indications admin May 25, 2024 Medicine Takeda's TAK-861 Shows Promising Results in Phase IIb Trial for Narcolepsy Type 1 admin February 12, 2024 Medicine BCS Financial Introduces Employer Group Gene Therapy Stop Loss admin October 7, 2024 Medicine FDA Approves BeiGene’s Tevimbra for Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma admin January 3, 2025
Medicine Degron Therapeutics, Takeda Ink Exclusive License and Collaboration Agreement to Develop Molecule Degraders Targeting Multiple Indications admin May 25, 2024
Medicine Takeda's TAK-861 Shows Promising Results in Phase IIb Trial for Narcolepsy Type 1 admin February 12, 2024
Medicine FDA Approves BeiGene’s Tevimbra for Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma admin January 3, 2025